Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DocGo (DCGO) Cash & Equivalents (2020 - 2025)

Historic Cash & Equivalents for DocGo (DCGO) over the last 6 years, with Q3 2025 value amounting to $73.4 million.

  • DocGo's Cash & Equivalents fell 1800.03% to $73.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $73.4 million, marking a year-over-year decrease of 1800.03%. This contributed to the annual value of $89.2 million for FY2024, which is 5052.71% up from last year.
  • Per DocGo's latest filing, its Cash & Equivalents stood at $73.4 million for Q3 2025, which was down 1800.03% from $104.2 million recorded in Q2 2025.
  • DocGo's Cash & Equivalents' 5-year high stood at $198.1 million during Q2 2022, with a 5-year trough of $59319.0 in Q3 2021.
  • For the 5-year period, DocGo's Cash & Equivalents averaged around $93.4 million, with its median value being $89.2 million (2024).
  • Per our database at Business Quant, DocGo's Cash & Equivalents soared by 28580965.63% in 2022 and then crashed by 6879.55% in 2023.
  • DocGo's Cash & Equivalents (Quarter) stood at $175.5 million in 2021, then decreased by 10.37% to $157.3 million in 2022, then tumbled by 62.32% to $59.3 million in 2023, then skyrocketed by 50.53% to $89.2 million in 2024, then fell by 17.8% to $73.4 million in 2025.
  • Its Cash & Equivalents stands at $73.4 million for Q3 2025, versus $104.2 million for Q2 2025 and $79.0 million for Q1 2025.